NCT04449666

Brief Summary

Neuropsychological and functional long-term consequences of subarachnoid hemorrhages (SAH) represent a great challenge, since sometimes considerable cognitive deficits occur without evidence of substantial brain damage. In this study, we want to examine if the frequently observed memory deficits are associated with hippocampal atrophy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
7mo left

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jun 2020Dec 2026

Study Start

First participant enrolled

June 15, 2020

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 18, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 29, 2020

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

6 years

First QC Date

June 18, 2020

Last Update Submit

September 18, 2025

Conditions

Keywords

Neurological rehabilitationHippocampal volumeMemory deficits

Outcome Measures

Primary Outcomes (1)

  • Changed hippocampal volume in aSAB

    Hypothesis: patients have smaller hippocampal volume than healthy control subjects. For the hippocampal volume a structural MRI scan (3D-MPRAGE) is obtained

    2 weeks

Secondary Outcomes (5)

  • Changed memory function in aSAB

    2 weeks

  • Influence of the type of therapy on the hippocampal volume

    2 weeks

  • Influence of the lesion site on the hippocampal volume

    2 weeks

  • Interrater reliability

    2 weeks

  • Changed intracranial volume in aSAB

    2 weeks

Study Arms (2)

Experimental group

Patients undergoing neurological rehabilitation after aneurysmal subarachnoid hemorrhage

Diagnostic Test: Neuropsychological assessment and structural MRI

Control group

Healthy adults controlled for age, gender and educational status

Diagnostic Test: Neuropsychological assessment and structural MRI

Interventions

Complex neuropsychological assessment testing attentional and memory functions. Additionally, a structural MRI is measured.

Control groupExperimental group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

neurological rehabilitation patients with aneurysmal subarachnoid hemorrhage (Hunt \& Hess grade I or II)

You may qualify if:

  • neurological rehabilitation patients in phase B - D
  • at minimum eight weeks after disease onset
  • aneurysmal subarachnoid hemorrhage (Hunt \& Hess grade I or II)
  • written consent from the patient's legal representative

You may not qualify if:

  • insufficient cardiorespiratory stability
  • previous brain damage
  • mental disorders (dementia, depression)
  • colonization with multi-resistant pathogens
  • MRI contraindications
  • claustrophobia
  • weight \> 120 kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BDH-Clinic Hessisch Oldendorf

Hessisch Oldendorf, 31840, Germany

RECRUITING

Related Publications (1)

  • Bendel P, Koivisto T, Hanninen T, Kolehmainen A, Kononen M, Hurskainen H, Pennanen C, Vanninen R. Subarachnoid hemorrhage is followed by temporomesial volume loss: MRI volumetric study. Neurology. 2006 Aug 22;67(4):575-82. doi: 10.1212/01.wnl.0000230221.95670.bf.

    PMID: 16924007BACKGROUND

MeSH Terms

Conditions

Nervous System DiseasesSubarachnoid HemorrhageMemory Disorders

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsNeurobehavioral ManifestationsNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Jens D Rollnik, MD

    BDH-Clinic Hessisch Oldendorf

    STUDY DIRECTOR
  • Melanie Boltzmann, PhD

    BDH-Clinic Hessisch Oldendorf

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2020

First Posted

June 29, 2020

Study Start

June 15, 2020

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

September 19, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Period of availability begins when results are published, at the earliest in Dec 2022
Access Criteria
IPD can be obtained from the principal investigator upon reasonable request.

Locations